首页 | 本学科首页   官方微博 | 高级检索  
   检索      

循环长链非编码RNA作为生物标志物在肿瘤分子诊断中的应用
引用本文:江楠,田海华,潘金昌,龚朝辉.循环长链非编码RNA作为生物标志物在肿瘤分子诊断中的应用[J].生物工程学报,2017,33(6):910-922.
作者姓名:江楠  田海华  潘金昌  龚朝辉
作者单位:1 宁波大学医学院 生物化学与分子生物学研究所,浙江 宁波 315211,1 宁波大学医学院 生物化学与分子生物学研究所,浙江 宁波 315211; 2 宁波市康宁医院检验科,浙江 宁波 315201,1 宁波大学医学院 生物化学与分子生物学研究所,浙江 宁波 315211,1 宁波大学医学院 生物化学与分子生物学研究所,浙江 宁波 315211
基金项目:浙江省自然科学基金 (No. LY15C060003),宁波市自然科学基金 (No. 2015A610220),宁波市社发科技攻关项目 (No. 2014C50058)、宁波大学王宽诚教育基金,宁波大学大学生科研创新计划重点项目 (No. 2016002) 资助。
摘    要:长链非编码RNA(Long noncoding RNA,lncRNA)被发现广泛参与基因表达、表观遗传调控和X染色体失活等重要生命过程,还与肿瘤发生和发展密切相关。lncRNA可能以微泡、外泌体或蛋白质复合物形式进入人体循环系统中,形成循环lncRNA稳定而广泛存在于血液、尿液等体液中。文中简要回顾了近来关于循环lncRNA的来源,以及作为生物标志物的检测方法,着重总结分析了循环lncRNA作为潜在肿瘤生物标志物在肺癌、乳腺癌、胃癌、肝癌、结直肠癌和前列腺癌等常见恶性肿瘤中的早期诊断价值。与传统生物标志物相比,循环lncRNA具有作为新型生物标志物的独特优势和临床应用价值。

关 键 词:循环长链非编码RNA,肿瘤,生物标志物,分子诊断
收稿时间:2016/11/30 0:00:00

Circulating long noncoding RNAs as biomarkers in tumor diagnosis
Nan Jiang,Haihua Tian,Jinchang Pan and Zhaohui Gong.Circulating long noncoding RNAs as biomarkers in tumor diagnosis[J].Chinese Journal of Biotechnology,2017,33(6):910-922.
Authors:Nan Jiang  Haihua Tian  Jinchang Pan and Zhaohui Gong
Institution:1 Institute of Biochemistry and Molecular Biology, Medical School of Ningbo University, Ningbo 315211, Zhejiang, China,1 Institute of Biochemistry and Molecular Biology, Medical School of Ningbo University, Ningbo 315211, Zhejiang, China; 2 Department of Laboratory Medicine, Ningbo Kangning Hospital, Ningbo 315201, Zhejiang, China,1 Institute of Biochemistry and Molecular Biology, Medical School of Ningbo University, Ningbo 315211, Zhejiang, China and 1 Institute of Biochemistry and Molecular Biology, Medical School of Ningbo University, Ningbo 315211, Zhejiang, China
Abstract:Long noncoding RNAs (lncRNAs) are involved in vital life processes of gene expression, epigenetic regulation and X-chromosome inactivation. lncRNAs are also closely associated with tumor initiation and progression. Moreover, lncRNAs may enter human circulation system in the form of microvesicle or exosome, or in combination with RNA binding protein. Interestingly, the circulating lncRNAs are widely existed in body fluids, such as blood and urine. We review the origin of circulating lncRNAs, and the detection methods as potential biomarkers. We focus on the early diagnosis value of circulating lncRNAs as tumor biomarkers in lung, breast, gastric, liver, colorectal and prostate cancers. Compared with the traditional biomarkers, the circulating lncRNAs show the unique advantages and clinical values as novel biomarkers.
Keywords:circulating lncRNA  tumor  biomarker  molecular diagnosis
本文献已被 CNKI 等数据库收录!
点击此处可从《生物工程学报》浏览原始摘要信息
点击此处可从《生物工程学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号